Cargando…
Effector immune cells in chronic lung allograft dysfunction: A systematic review
Chronic lung allograft dysfunction (CLAD) remains the major barrier to long‐term survival after lung transplantation and improved insight into its underlying immunological mechanisms is critical to better understand the disease and to identify treatment targets. We systematically searched the electr...
Autores principales: | Bos, Saskia, Filby, Andrew J., Vos, Robin, Fisher, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426626/ https://www.ncbi.nlm.nih.gov/pubmed/35137398 http://dx.doi.org/10.1111/imm.13458 |
Ejemplares similares
-
Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle
por: Bos, Saskia, et al.
Publicado: (2022) -
Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review
por: Bos, Saskia, et al.
Publicado: (2021) -
Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation
por: Suwara, Monika I, et al.
Publicado: (2014) -
Molecular monitoring of lung allograft health: is it ready for routine clinical use?
por: Pradère, Pauline, et al.
Publicado: (2023) -
Aspergillus-Specific IgG Antibodies are Associated With Fungal-Related Complications and Chronic Lung Allograft Dysfunction After Lung Transplantation
por: Beeckmans, Hanne, et al.
Publicado: (2023)